Terpenoid ID | TKC206770 | |
Cell line | 0 | |
Protein target | 15 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 77 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC206770 | Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH2 | 31623 | nM | Potency |
TKC206770 | P00352 | Retinal dehydrogenase 1 | ALDH1A1 | 13 | nM | Potency |
TKC206770 | Q16637 | Survival motor neuron protein | SMN1 | 6 | nM | Potency |
TKC206770 | Q16637 | Survival motor neuron protein | SMN2 | 6 | nM | Potency |
TKC206770 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 18356 | nM | Potency |
TKC206770 | P06276 | Cholinesterase | BCHE | 1550 | nM | IC50 |
TKC206770 | P10275 | Androgen receptor | AR | 224 | nM | Potency |
TKC206770 | P15207 | Androgen receptor | Ar | 64 | nM | IC50 |
TKC206770 | P84022 | Mothers against decapentaplegic homolog 3 | SMAD3 | 6310 | nM | Potency |
TKC206770 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 66824 | nM | Potency |
TKC206770 | P19838 | Nuclear factor NF-kappa-B p105 subunit | NFKB1 | 31623 | nM | Potency |
TKC206770 | Q9UNA4 | DNA polymerase iota | POLI | 89125 | nM | Potency |
TKC206770 | P11511 | Aromatase | CYP19A1 | 20 | nM | Ki |
TKC206770 | O75496 | Geminin | GMNN | 23109 | nM | Potency |
TKC206770 | Q13148 | TAR DNA-binding protein 43 | TARDBP | 35481 | nM | Potency |
TKC206770 | P03372 | Estrogen receptor | ESR1 | 5012 | nM | Potency |
TKC206770 | P04150 | Glucocorticoid receptor | NR3C1 | 2818 | nM | Potency |
TKC206770 | P28482 | Mitogen-activated protein kinase 1 | MAPK1 | 39811 | nM | Potency |
TKC206770 | Q9WKE8 | Reverse transcriptase | reverse tr | >200 | ug.mL-1 | IC50 |
TKC206770 | Q9WKE8 | Reverse transcriptase | reverse tr | >698000 | nM | IC50 |
TKC206770 | P54132 | Bloom syndrome protein | BLM | 251189 | nM | Potency |
TKC206770 | Q01453 | Peripheral myelin protein 22 | PMP22 | 84921 | nM | Potency |
TKC206770 | Q6W5P4 | Neuropeptide S receptor | NPSR1 | 251 | nM | Potency |
TKC206770 | Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | HSD17B10 | 25119 | nM | Potency |
TKC206770 | P49798 | Regulator of G-protein signaling 4 | RGS4 | 6 | nM | Potency |
TKC206770 | Q9NR56 | Muscleblind-like protein 1 | MBNL1 | 100 | nM | Potency |
TKC206770 | P51450 | Nuclear receptor ROR-gamma | Rorc | 2818 | nM | Potency |
TKC206770 | P02545 | Prelamin-A/C | LMNA | 10000 | nM | Potency |
TKC206770 | Q03181 | Peroxisome proliferator-activated receptor delta | PPARD | 31623 | nM | Potency |
TKC206770 | P19793 | Retinoic acid receptor RXR-alpha | RXRA | 7080 | nM | Potency |
TKC206770 | P16473 | Thyrotropin receptor | TSHR | 6310 | nM | Potency |
TKC206770 | P10145 | Interleukin-8 | CXCL8 | 74978 | nM | Potency |
TKC206770 | P51449 | Nuclear receptor ROR-gamma | RORC | 33492 | nM | Potency |
TKC206770 | O15245 | Solute carrier family 22 member 1 | SLC22A1 | 65 | % | Inhibition |
TKC206770 | Q194T2 | Non-structural protein 1 | NS1 | 35481 | nM | Potency |
TKC206770 | P06401 | Progesterone receptor | PGR | -1 | log(RBA) | |
TKC206770 | P62826 | GTP-binding nuclear protein Ran | RAN | 6513 | nM | Potency |
TKC206770 | P25094 | Peripheral myelin protein 22 | Pmp22 | 10182 | nM | Potency |
TKC206770 | O35627 | Nuclear receptor subfamily 1 group I member 3 | Nr1i3 | 56 | % | Remaining activity |
TKC206770 | P04278 | Sex hormone-binding globulin | SHBG | 35 | nM | Kd |
TKC206770 | P06186 | Progesterone receptor | PGR | -1 | log(RBA) | |
TKC206770 | P08185 | Corticosteroid-binding globulin | SERPINA6 | 1738 | nM | Ki |
TKC206770 | Q28590 | Progesterone receptor | PGR | -1 | log(RBA) | |
TKC206770 | Q9GK37 | Corticosteroid-binding globulin | Serpina6 | 6 | Log 1/K | |
TKC206770 | P37058 | Testosterone 17-beta-dehydrogenase 3 | HSD17B3 | 489 | nM | IC50 |
TKC206770 | P37058 | Testosterone 17-beta-dehydrogenase 3 | HSD17B3 | 758 | nM | IC50 |
TKC206770 | P37058 | Testosterone 17-beta-dehydrogenase 3 | HSD17B3 | 758 | nM | IC50 |
TKC206770 | P05804 | Beta-glucuronidase | uidA | 430000 | nM | IC50 |
TKC206770 | P18405 | 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | SRD5A1 | 2700 | nM | IC50 |
TKC206770 | P31213 | 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | SRD5A2 | 84 | nM | IC50 |
TKC206770 | P22443 | Aromatase | Cyp19a1 | 138 | Mean |
Uniport ID | Uniport Name | ICD-11 | Disease |
---|---|---|---|
Q12809 | KCNH2_HUMAN | ICD-11: BD10-BD1Z | failure |
Q12809 | KCNH2_HUMAN | ICD-11: 7A00-7B2Z | disorder |
Q12809 | KCNH2_HUMAN | ICD-11: 1F40-1F45 | Malaria |
Q12809 | KCNH2_HUMAN | ICD-11: 8A40 | sclerosis |
Q12809 | KCNH2_HUMAN | ICD-11: MG30-MG3Z | Pain |
Q12809 | KCNH2_HUMAN | ICD-11: BC9Z | arrhythmia |
Q12809 | KCNH2_HUMAN | ICD-11: BA40 | pectoris |
Q12809 | KCNH2_HUMAN | ICD-11: BC65 | arrhythmia |
Q12809 | KCNH2_HUMAN | ICD-11: 2C73 | cancer |
Q16637 | SMN_HUMAN | ICD-11: 8B61 | atrophy |
Q16637 | SMN_HUMAN | ICD-11: 8B61 | atrophy |
Q16637 | SMN_HUMAN | ICD-11: 8B61 | atrophy |
Q16637 | SMN_HUMAN | ICD-11: 8B61 | atrophy |
P06276 | CHLE_HUMAN | ICD-11: MG30-MG3Z | Pain |
P06276 | CHLE_HUMAN | ICD-11: MB47 | abnormality |
P06276 | CHLE_HUMAN | ICD-11: 8A20 | disease |
P06276 | CHLE_HUMAN | ICD-11: 6D71 | disorder |
P06276 | CHLE_HUMAN | ICD-11: NE61 | effect |
P06276 | CHLE_HUMAN | ICD-11: N.A. | Toxicity |
P06276 | CHLE_HUMAN | ICD-11: NE6Z | effect |
P10275 | ANDR_HUMAN | ICD-11: ED80 | vulgaris |
P10275 | ANDR_HUMAN | ICD-11: 2A60 | leukaemia |
P10275 | ANDR_HUMAN | ICD-11: DB94 | disease |
P10275 | ANDR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P10275 | ANDR_HUMAN | ICD-11: BA00-BE2Z | disease |
P10275 | ANDR_HUMAN | ICD-11: CA22 | disease |
P10275 | ANDR_HUMAN | ICD-11: GA34 | pain |
P10275 | ANDR_HUMAN | ICD-11: 5C72 | Hypo-osmolality/hyponatraemia |
P10275 | ANDR_HUMAN | ICD-11: FB83 | disorder |
P10275 | ANDR_HUMAN | ICD-11: 2C60-2C6Z | tumour |
P10275 | ANDR_HUMAN | ICD-11: 5A60-5A61 | disorder |
P10275 | ANDR_HUMAN | ICD-11: 2C82 | cancer |
P10275 | ANDR_HUMAN | ICD-11: 5A81 | dysfunction |
P10275 | ANDR_HUMAN | ICD-11: GA90 | hyperplasia |
P10275 | ANDR_HUMAN | ICD-11: ED70 | Alopecia |
P10275 | ANDR_HUMAN | ICD-11: GB61 | disease |
P10275 | ANDR_HUMAN | ICD-11: DB61-GB90 | Thrombosis |
P10275 | ANDR_HUMAN | ICD-11: QA21 | management |
P10275 | ANDR_HUMAN | ICD-11: BD10-BD1Z | failure |
P10275 | ANDR_HUMAN | ICD-11: FB32-FB3Z | disorder |
P10275 | ANDR_HUMAN | ICD-11: 8C70 | dystrophy |
P10275 | ANDR_HUMAN | ICD-11: CA25 | fibrosis |
P10275 | ANDR_HUMAN | ICD-11: MG30-MG3Z | Pain |
P10275 | ANDR_HUMAN | ICD-11: MG20 | Cachexia |
P10275 | ANDR_HUMAN | ICD-11: 6B60 | disorder |
P10275 | ANDR_HUMAN | ICD-11: 2C94 | cancer |
P10275 | ANDR_HUMAN | ICD-11: DA24 | Oesophagitis |
P10275 | ANDR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P10275 | ANDR_HUMAN | ICD-11: GA90 | hyperplasia |
P10275 | ANDR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P10275 | ANDR_HUMAN | ICD-11: 2C82 | cancer |
P10275 | ANDR_HUMAN | ICD-11: ED80 | vulgaris |
P10275 | ANDR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P84022 | SMAD3_HUMAN | ICD-11: 1F00 | infection |
P84022 | SMAD3_HUMAN | ICD-11: GC01 | fibrosis |
Q16236 | NF2L2_HUMAN | ICD-11: 8A03 | disorder |
Q16236 | NF2L2_HUMAN | ICD-11: 2C60-2C6Y | cancer |
Q16236 | NF2L2_HUMAN | ICD-11: 9C61 | Glaucoma |
Q16236 | NF2L2_HUMAN | ICD-11: 2C25 | cancer |
Q16236 | NF2L2_HUMAN | ICD-11: 9B75 | degeneration |
Q16236 | NF2L2_HUMAN | ICD-11: 2C30 | Melanoma |
Q16236 | NF2L2_HUMAN | ICD-11: 6E20-6E8Z | disorder |
Q16236 | NF2L2_HUMAN | ICD-11: BB01 | hypertension |
Q16236 | NF2L2_HUMAN | ICD-11: 8B01 | haemorrhage |
Q16236 | NF2L2_HUMAN | ICD-11: MF8Y | sympton |
Q16236 | NF2L2_HUMAN | ICD-11: DB92 | disease |
Q16236 | NF2L2_HUMAN | ICD-11: 5C5A | deficiency |
Q16236 | NF2L2_HUMAN | ICD-11: 8B60 | disease |
Q16236 | NF2L2_HUMAN | ICD-11: 8A40 | sclerosis |
P19838 | NFKB1_HUMAN | ICD-11: 8C70 | dystrophy |
P19838 | NFKB1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P19838 | NFKB1_HUMAN | ICD-11: 5A11 | mellitus |
P11511 | CP19A_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P11511 | CP19A_HUMAN | ICD-11: 5A70 | syndrome |
P11511 | CP19A_HUMAN | ICD-11: DA24 | Oesophagitis |
P11511 | CP19A_HUMAN | ICD-11: GA10 | Endometriosis |
P11511 | CP19A_HUMAN | ICD-11: 8C0Z | Neuropathy |
P11511 | CP19A_HUMAN | ICD-11: 2C94 | cancer |
P11511 | CP19A_HUMAN | ICD-11: GA91 | disease |
Q13148 | TADBP_HUMAN | ICD-11: 2A60 | leukaemia |
Q13148 | TADBP_HUMAN | ICD-11: 8A20 | disease |
P03372 | ESR1_HUMAN | ICD-11: ED80 | vulgaris |
P03372 | ESR1_HUMAN | ICD-11: 8E01 | disease |
P03372 | ESR1_HUMAN | ICD-11: 2D11 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P03372 | ESR1_HUMAN | ICD-11: QA21 | management |
P03372 | ESR1_HUMAN | ICD-11: GA12 | Dyspareunia |
P03372 | ESR1_HUMAN | ICD-11: GA31 | infertility |
P03372 | ESR1_HUMAN | ICD-11: FB83 | disorder |
P03372 | ESR1_HUMAN | ICD-11: GB04 | infertility |
P03372 | ESR1_HUMAN | ICD-11: GA30 | disorder |
P03372 | ESR1_HUMAN | ICD-11: GA20 | disorder |
P03372 | ESR1_HUMAN | ICD-11: 8A40 | sclerosis |
P03372 | ESR1_HUMAN | ICD-11: 5A60-5A61 | disorder |
P03372 | ESR1_HUMAN | ICD-11: LD24 | anomaly |
P03372 | ESR1_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P03372 | ESR1_HUMAN | ICD-11: GA02 | Vaginitis |
P03372 | ESR1_HUMAN | ICD-11: 1A24-1D9Z | infection |
P03372 | ESR1_HUMAN | ICD-11: GA10 | Endometriosis |
P03372 | ESR1_HUMAN | ICD-11: GA1Y | disorder |
P03372 | ESR1_HUMAN | ICD-11: GA34 | pain |
P03372 | ESR1_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
P03372 | ESR1_HUMAN | ICD-11: 2E65 | carcinoma |
P03372 | ESR1_HUMAN | ICD-11: 5A10 | mellitus |
P03372 | ESR1_HUMAN | ICD-11: 2C82 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2A00 | cancer |
P03372 | ESR1_HUMAN | ICD-11: 2D50-2E2Z | tumour |
P03372 | ESR1_HUMAN | ICD-11: N.A. | Irregularities |
P03372 | ESR1_HUMAN | ICD-11: 1F8Y | disease |
P03372 | ESR1_HUMAN | ICD-11: MG30-MG3Z | Pain |
P03372 | ESR1_HUMAN | ICD-11: 9A01-9A0Z | disorder |
P03372 | ESR1_HUMAN | ICD-11: 6B60 | disorder |
P03372 | ESR1_HUMAN | ICD-11: 3B64 | Thrombocytopenia |
P03372 | ESR1_HUMAN | ICD-11: 9A2Y-9C40 | Atrophy |
P03372 | ESR1_HUMAN | ICD-11: ME82 | pain |
P03372 | ESR1_HUMAN | ICD-11: HA00-HA01 | dysfunction |
P03372 | ESR1_HUMAN | ICD-11: 2A60-2B33 | Leukaemia |
P04150 | GCR_HUMAN | ICD-11: 5A2Y | complication |
P04150 | GCR_HUMAN | ICD-11: DD72 | colitis |
P04150 | GCR_HUMAN | ICD-11: 8A40 | sclerosis |
P04150 | GCR_HUMAN | ICD-11: 8C70 | dystrophy |
P04150 | GCR_HUMAN | ICD-11: 2C82 | cancer |
P04150 | GCR_HUMAN | ICD-11: FA20 | arthritis |
P04150 | GCR_HUMAN | ICD-11: 5A11 | mellitus |
P04150 | GCR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P04150 | GCR_HUMAN | ICD-11: 4A01 | immunodeficiency |
P04150 | GCR_HUMAN | ICD-11: 5A71 | disorder |
P04150 | GCR_HUMAN | ICD-11: 4A80-4A8Z | disorder |
P04150 | GCR_HUMAN | ICD-11: CA23 | Asthma |
P04150 | GCR_HUMAN | ICD-11: EA80 | eczema |
P04150 | GCR_HUMAN | ICD-11: CA22 | disease |
P04150 | GCR_HUMAN | ICD-11: 5A70 | syndrome |
P04150 | GCR_HUMAN | ICD-11: EA80-EA89 | Eczema |
P04150 | GCR_HUMAN | ICD-11: 8A40 | sclerosis |
P04150 | GCR_HUMAN | ICD-11: 8C70 | dystrophy |
P04150 | GCR_HUMAN | ICD-11: DA24 | Oesophagitis |
P04150 | GCR_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P04150 | GCR_HUMAN | ICD-11: FA20 | arthritis |
P04150 | GCR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P04150 | GCR_HUMAN | ICD-11: ND51 | injury |
P04150 | GCR_HUMAN | ICD-11: CA08 | rhinitis |
P04150 | GCR_HUMAN | ICD-11: 1F00 | infection |
P04150 | GCR_HUMAN | ICD-11: AA00-AA13 | externa |
P04150 | GCR_HUMAN | ICD-11: 6C40 | abuse |
P04150 | GCR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P04150 | GCR_HUMAN | ICD-11: 6A70-6A7Z | Depression |
P04150 | GCR_HUMAN | ICD-11: 6A60-6E23 | disorder |
P04150 | GCR_HUMAN | ICD-11: 5A11 | mellitus |
P04150 | GCR_HUMAN | ICD-11: 5B55-5B5F | deficiency |
P04150 | GCR_HUMAN | ICD-11: 9B71 | Retinopathy |
P04150 | GCR_HUMAN | ICD-11: 6B00-6B0Z | disorder |
P28482 | MK01_HUMAN | ICD-11: 2C30 | Melanoma |
P28482 | MK01_HUMAN | ICD-11: 2C10 | cancer |
P28482 | MK01_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P28482 | MK01_HUMAN | ICD-11: BD52 | disorder |
P28482 | MK01_HUMAN | ICD-11: 4A80-4A8Z | disorder |
P28482 | MK01_HUMAN | ICD-11: NE84 | rejection |
P28482 | MK01_HUMAN | ICD-11: 2A90 | lymphoma |
P28482 | MK01_HUMAN | ICD-11: FA20 | arthritis |
Q03181 | PPARD_HUMAN | ICD-11: DB92 | disease |
Q03181 | PPARD_HUMAN | ICD-11: 5A11 | mellitus |
Q03181 | PPARD_HUMAN | ICD-11: DB96 | disease |
Q03181 | PPARD_HUMAN | ICD-11: 5C80 | Hyper-lipoproteinaemia |
Q03181 | PPARD_HUMAN | ICD-11: 5B80-5B81 | Obesity |
Q03181 | PPARD_HUMAN | ICD-11: 8A20 | disease |
Q03181 | PPARD_HUMAN | ICD-11: 5C80-5C81 | Dyslipidemia |
Q03181 | PPARD_HUMAN | ICD-11: 5C50-5D2Z | disorder |
Q03181 | PPARD_HUMAN | ICD-11: 5A10 | mellitus |
Q03181 | PPARD_HUMAN | ICD-11: 8A04-8D87 | disease |
P19793 | RXRA_HUMAN | ICD-11: 2B57 | sarcoma |
P19793 | RXRA_HUMAN | ICD-11: 2B01 | fungoides |
P16473 | TSHR_HUMAN | ICD-11: 5A00 | Hypo-thyroidism |
P16473 | TSHR_HUMAN | ICD-11: 2D10 | cancer |
P10145 | IL8_HUMAN | ICD-11: MG30-MG3Z | Pain |
P10145 | IL8_HUMAN | ICD-11: 1D6Y | COVID-19 |
P10145 | IL8_HUMAN | ICD-11: 2C30 | Melanoma |
P10145 | IL8_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P10145 | IL8_HUMAN | ICD-11: 5A10 | mellitus |
P51449 | RORG_HUMAN | ICD-11: 4A40-4A45 | disease |
P51449 | RORG_HUMAN | ICD-11: 2C25 | cancer |
P51449 | RORG_HUMAN | ICD-11: EA90 | Psoriasis |
P51449 | RORG_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P51449 | RORG_HUMAN | ICD-11: DD70 | disease |
P51449 | RORG_HUMAN | ICD-11: 8A40 | sclerosis |
P51449 | RORG_HUMAN | ICD-11: BD40 | disease |
P51449 | RORG_HUMAN | ICD-11: 2C12 | cancer |
P51449 | RORG_HUMAN | ICD-11: FA20 | arthritis |
P06401 | PRGR_HUMAN | ICD-11: 2C60-2C6Y | cancer |
P06401 | PRGR_HUMAN | ICD-11: QA21 | management |
P06401 | PRGR_HUMAN | ICD-11: GA20 | disorder |
P06401 | PRGR_HUMAN | ICD-11: JB00 | labour/delivery |
P06401 | PRGR_HUMAN | ICD-11: 2A00-2F9Z | tumour/cancer |
P06401 | PRGR_HUMAN | ICD-11: GA10 | Endometriosis |
P06401 | PRGR_HUMAN | ICD-11: GA34 | pain |
P06401 | PRGR_HUMAN | ICD-11: 2C76 | cancer |
P06401 | PRGR_HUMAN | ICD-11: 2E86 | fibroid |
P06401 | PRGR_HUMAN | ICD-11: FB83 | disorder |
P06401 | PRGR_HUMAN | ICD-11: GA6Z | disease |
P08185 | CBG_HUMAN | ICD-11: CA23 | Asthma |
P08185 | CBG_HUMAN | ICD-11: 1A00-CA43 | inflammation |
P08185 | CBG_HUMAN | ICD-11: CB40-CB7Z | disease |
P08185 | CBG_HUMAN | ICD-11: 9B71 | Retinopathy |
P05804 | BGLR_ECOLI | ICD-11: DA94 | toxicity |
P18405 | S5A1_HUMAN | ICD-11: GA91 | disease |
P18405 | S5A1_HUMAN | ICD-11: ED80 | vulgaris |
P31213 | S5A2_HUMAN | ICD-11: GA90 | hyperplasia |